BioSpace News Archive

Acumen Pharmaceuticals, Inc. reported financial results for the first quarter of 2023 and provided a business update.

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company, today provided a corporate update and reported financial results for the first quarter of 2023.

Rallybio Corporation (Nasdaq: RLYB) today reported financial results for the first quarter ended March 31, 2023 and provided an update on recent program and corporate developments.

Anokion SA today announced favorable new pharmacodynamic and pharmacokinetic data from the company’s completed Phase 1 clinical trial evaluating KAN-101 as a treatment for celiac disease.

Heart Test Laboratories, Inc. today announces completion of patient enrollment for its MyoVista wav ECG pivotal study for FDA De Novo submission.

Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company with an extensive pipeline of clinical and preclinical-stage cancer treatments, today provided a corporate update and reported financial results for the first quarter 2023.

Boundless Bio today announced that the first patient has been dosed with BBI-355 in a first-in-human, Phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumors with oncogene amplifications (NCT05827614).

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among U.S. patient groups who reported working with, or who were familiar with the company.

Universal Diagnostics today announced the results of a large international multi-cohort case-control which demonstrate that cell-free DNA methylation and fragmentation signals combined with machine-learning can be used to detect early-stage colorectal cancer (CRC) with 91% and pre-cancerous advanced adenomas (AA) with 54% sensitivity at 92% specificity.

Milestone Scientific Inc. today announced that it has commenced sales of CompuFlo ® Epidural disposables into The Sports and Spine Center in Tualatin, Oregon.